Non-sulfonamide bacterial CA inhibitors
The Enzymes · 2024
DOI: 10.1016/bs.enz.2024.06.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Enzymes, 2024. Verfasst von Fabrizio Carta. Beteiligte Einrichtung: NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Sesto Fiorentino, Florence, Italy. Electronic addres…. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrases. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Non-sulfonamide chemical moieties able to inhibit the bacterial (b) expressed Carbonic Anhydrases (CAs; EC 4.2.1.1) constitute an important alternative to the prototypic modulators discussed in Chapter 6, as give access to large and variegate chemical classes, also of the natural origin. This contribution reports the main classes of compounds profiled in vitro on the bCAs and thus may be worth developing for the validation process of this class of enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Sesto Fiorentino, Florence, Italy. Electronic address: fabrizio.carta@unifi.it.
Zitieren
APA
Carta, F. (2024). Non-sulfonamide bacterial CA inhibitors. The Enzymes. https://doi.org/10.1016/bs.enz.2024.06.007
Vancouver
Carta F. Non-sulfonamide bacterial CA inhibitors. The Enzymes. 2024. doi:10.1016/bs.enz.2024.06.007
BibTeX
@article{Carta2024,
author = {Carta, Fabrizio},
title = {Non-sulfonamide bacterial CA inhibitors},
journal = {The Enzymes},
year = {2024},
doi = {10.1016/bs.enz.2024.06.007}
}
EUVIMED